Massive 'terror attack' averted: Histadrut to decide on future layoffs at Teva

While claiming to be acting in the interest of Israel’s workers, facts are stubborn things, and the Histadrut’s fingerprints are all over an Israeli society that is being hobbled by a skyrocketing cost of living.

October 17, 2013 14:02
3 minute read.
Histadrut chair Ofer Eini at Labor Court

Histadrut chair Ofer Eini at Labor Court_311. (photo credit: Marc Israel Sellem)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


Following a wave of public criticism over the decision to lay off 700-800 employees in Israel as part of a company-wide restructuring program, Teva Pharmaceutical Industries announced Tuesday that it had reached an agreement with the Histadrut Labor Federation not to dismiss any of its Israeli workers without the federation's consent.

The debate over the fate of  Teva’s workforce in Israel reached a fever pitch earlier in the week when opposition leader Shelly Yachimovich (Labor) called Teva's plan "a mass terror attack," saying that given the near-zero taxes the pharmaceutical giant pays the state, the plan was an "act of cannibalism."


Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

Cookie Settings